Procter & Gamble Co


  • Apple’s Co-Founder and Chief Executive Steve Jobs is the “ultimate CEO who matters,” according to a ranking by Barron’s magazine.  The annual ranking of top CEOs from around the world seeks to identify the corporate leaders who have top-notch reputations in the financial community and would be missed by investors if they unexpectedly left their jobs.

  • Sector Rotation for Dummies Monday, 19 Mar 2007 | 6:49 PM ET

    There are two kinds of companies in the market – cyclical and secular. One of the most important moves in the game is to know when to shift your money from one to the other. Luckily, Cramer knows the precise moment.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • The fallout in the subprime mortgage industry continues to trouble the markets, and analysts expect the issue to be at the forefront of investor concerns next week.

  • Stocks closed higher as investors overcame concerns about subprime lending to spark a late-day rally.  "We're going through a short-term bounce," Mark Arbeter, Chief Technical Strategist at Standard & Poor's, told CNBC.  "Volume, so far, on the upside has been fairly light, which is not encouraging. "

  • SCA to Buy P&G European Tissue Unit Monday, 12 Mar 2007 | 5:13 AM ET

    Swedish hygiene and paper product maker SCA said on Monday it had signed a deal to buy all of Procter & Gamble's  European tissue operations for 512 million euros ($672 million) in cash.

  • P&G Affirms Profit, Sales Guidance Friday, 9 Mar 2007 | 11:12 AM ET

    Consumer products giant Procter & Gamble stood by its forecast for the current quarter on Friday, but its shares slipped in early trading on concerns profit could miss Wall Street's expectations.

  • Portfolio Manager Lauds "Safety" Stocks Tuesday, 6 Mar 2007 | 10:38 AM ET

    Ted Parrish says investor risk hasn't really increased -- merely the "perception" of it. So the co-portfolio manager at Henssler Equity Fund says the key to riding the volatility wave is understanding that risk perception -- and hunting for perceived "stability."

  • Cramer's Cure for a Market Hangover Wednesday, 28 Feb 2007 | 6:13 PM ET

    After the trauma of a 416-point drop in the market, Cramer likes to go fishing – bottom fishing, actually. He has 25 years of experience angling through the wrecks of portfolios that belonged to less experienced fisherman and women, and today he’s going to share his secrets with you.

  • Stocks finished the day higher after the Fed chairman reassured investors that the economic outlook is not changed.  "The (markets) valuation, if anything, has gotten a little bit better," Goldman, Sachs chief U.S. investment strategist Abby Joseph Cohen said. "Going forward, what matters is that the global economy still looks good."

  • It's Time for the Lightning Round! Tuesday, 27 Feb 2007 | 6:38 PM ET

    Cramer tells you what to do with AT&T, Retail Ventures, Choice Hotels and more.

  • Procter & Gamble Plans $4 Billion Bond Issue - Source Tuesday, 27 Feb 2007 | 6:01 AM ET

    Procter & Gamble, the U.S. consumer products maker, is planning to issue $4 billion worth of bonds in three parts denominated in euros and dollars, a market source said according to Reuters.

  • Google to Sell Online Software Suite Thursday, 22 Feb 2007 | 1:10 PM ET

    Google  will begin selling corporate America an online suite of software that includes e-mail, word processing, spreadsheets and calendar management, escalating the Internet search leader's invasion on technological turf traditionally dominated by Microsoft and IBM.

  • P&G Seeks Buyer for Japan Adult Diaper Brand Thursday, 15 Feb 2007 | 6:37 AM ET

    Procter & Gamble said on Thursday it was seeking a buyer for its Japanese adult diaper business even as the market posts steady growth due to the country's greying population.

  • Stocks Finish Higher Ahead of Fed; Energy Leads Gains Tuesday, 30 Jan 2007 | 6:56 PM ET

    A sharp rise in crude oil prices failed to deter investors on Tuesday as they nibbled at stocks ahead of the Federal Reserve's decision on interest rates, set for release tomorrow afternoon.

  • Java Trades Up--Coffee Goes Online Tuesday, 30 Jan 2007 | 2:42 PM ET

    Coffee and computers: the modern business of both erupted simultaneously in the 1990s, born in Washington, Oregon and Northern California -- and riding out to conquer the rest of America and the world. So perhaps it's fitting that these two symbols of the pre-millennial new economy should come together at one nexus point: early next month, the trade in java is going....

  • But P&G shares. which had been trading at all-time highs, fell as organic sales fell short of expectations and third-quarter earnings were estimated to be a bit weaker than expected

  • Procter & Gamble and its smaller rival Colgate-Palmolive posted slightly better-than-expected quarterly profits, but the results failed to excite Wall Street.

  • Fed On The Clock and Oil Firms Up Tuesday, 30 Jan 2007 | 7:46 AM ET

    The Dow is pointing higher this morning as investors focus on the Fed's two day meeting and a bunch of big earning reports. European markets are slightly weaker and Asian stocks were mixed overnight. The yen remains lower against the dollar.

  • Dow Closes at Record High; Techs Lead as Oil Drops Thursday, 11 Jan 2007 | 7:24 PM ET

    The Dow climbed to a new record and the Nasdaq finished at a six year high as falling oil prices drove buyers into consumer, health care and technology stocks.

  • Fractured Sales? Wednesday, 27 Dec 2006 | 12:54 PM ET

    It looks like the Journal of the American Medical Association (JAMA) chose fractures as the theme of its new issue.  One study shows that taking a popular osteoporosis drug for 5 years and then going off of it for 5 years carries a residual beneficial effect almost as if the patient stayed on the drug for all 10 years. Merck paid for the study of its #3-selling drug, Fosamax. The only exception was a 55% increased risk of fractures of the spine for those who stopped taking Fosamax. Doctors say that means...